1 Min Read
June 29 (Reuters) - CHF Solutions Inc:
* CHF Solutions’ aquadex flexflow® aquapheresis system receives FDA IDE approval for clinical study for pediatric use Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.